Medicalgorithmics Summarizes the Q1 2025 51% revenue growth, positive EBITDA, and positive operating cash flow
Medicalgorithmics S.A., a developer of globally innovative AI algorithms and an ECG analysis platform, has published its report for the first quarter of 2026. The company generated consolidated sales revenue of PLN 10.2 million, representing a 51% year-over-year increase. EBITDA for the period amounted to PLN 1.1 million, and cash flow from operating activities was PLN 1.2 million. This means that the Company has remained above the cash break-even point at the operating level for the second consecutive quarter.